대장암 시장 보고서 : 동향, 예측, 경쟁 분석(-2030년)

Colorectal Cancer Trends and Forecast

The future of the global colorectal cancer market looks promising with opportunities in the urgery & radiation therapy, chemotherapy, targeted therapies, and resistance to pharmacological therapies markets. The global colorectal cancer market is expected to reach an estimated $21.9 billion by 2030 with a CAGR of 4.1% from 2024 to 2030. The major drivers for this market are growing geriatric population, increasing unhealthy food habits and odd food consumption timing of individual, and rising awareness towards colorectal cancer.

A more than 150-page report is developed to help in your business decisions.

Colorectal Cancer by Segment

The study includes a forecast for the global colorectal cancer by diagnosis, treatment, and region.

Colorectal Cancer Market by Diagnosis [Shipment Analysis by Value from 2018 to 2030]:

• Digital Rectal Examination
• Fecal Occult Blood Test
• Flexible Sigmoidoscopy
• Colonoscopy
• Virtual Colonoscopy

Colorectal Cancer Market by Treatment [Shipment Analysis by Value from 2018 to 2030]:

• Surgery and Radiation Therapy
• Chemotherapy
• Targeted Therapies
• Resistance to Pharmacological Therapies
• Others

Colorectal Cancer Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Colorectal Cancer Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies colorectal cancer companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the colorectal cancer companies profiled in this report include-

• Abbott Diagnostics
• Alere
• Beckman Coulter
• Clinical Genomics
• Companion Dx
• Hoffmann La Roche
• Debiopharm
• Vaccinogen BD

Colorectal Cancer Market Insights

Lucintel forecasts that digital rectal examination is expected to witness highest growth over the forecast period due to growing prominence for the various treatment procedures by performing accurate diagnostic tests.

Within this market, chemotherapy will remain the largest segment as it is generally a treatment with injectable cancer drugs into a vein or orally by mouth, which helps them directly reach body parts through the bloodstream travel and is the most commonly used method to treat colorectal cancer.

North America is expected to witness highest growth over the forecast period due to the increasing awareness among consumers about the diagnosis and treatment of colorectal cancer and growing government support to develop colorectal cancer procedures and drugs in this region.

Features of the Global Colorectal Cancer Market

Market Size Estimates: Colorectal cancer market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Colorectal cancer market size by diagnosis, treatment, and region. in terms of value ($B).

Regional Analysis: Colorectal cancer market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different diagnosis, treatment, and region.s for the colorectal cancer market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the colorectal cancer market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1. What is the colorectal cancer market size?

Answer: The global colorectal cancer market is expected to reach an estimated $21.9 billion by 2030.

Q.2. What is the growth forecast for colorectal cancer market?

Answer: The global colorectal cancer market is expected to grow with a CAGR of 4.1% from 2024 to 2030.

Q.3. What are the major drivers influencing the growth of the colorectal cancer market?

Answer: The major drivers for this market are growing geriatric population, increasing unhealthy food habits and odd food consumption timing of individual, and rising awareness towards colorectal cancer.

Q.4. What are the major segments for colorectal cancer market?

Answer: The future of the colorectal cancer market looks promising with opportunities in the urgery & radiation therapy, chemotherapy, targeted therapies, and resistance to pharmacological therapies markets.

Q.5. Who are the key colorectal cancer market companies?

Answer: Some of the key colorectal cancer companies are as follows:

• Abbott Diagnostics
• Alere
• Beckman Coulter
• Clinical Genomics
• Companion Dx
• Hoffmann La Roche
• Debiopharm
• Vaccinogen BD

Q.6. Which colorectal cancer market segment will be the largest in future?

Answer: Lucintel forecasts that digital rectal examination is expected to witness highest growth over the forecast period due to growing prominence for the various treatment procedures by performing accurate diagnostic tests.

Q.7. In colorectal cancer market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to the increasing awareness among consumers about the diagnosis and treatment of colorectal cancer and growing government support to develop colorectal cancer procedures and drugs in this region.

Q.8. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the colorectal cancer market by diagnosis (digital rectal examination, fecal occult blood test, flexible sigmoidoscopy, colonoscopy, and virtual colonoscopy), treatment (surgery & radiation therapy, chemotherapy, targeted therapies, resistance to pharmacological therapies, and others), and region. (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Colorectal Cancer Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Colorectal Cancer Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Colorectal Cancer Market by Diagnosis
  • 3.3.1: Digital Rectal Examination
  • 3.3.2: Fecal Occult Blood Test
  • 3.3.3: Flexible Sigmoidoscopy
  • 3.3.4: Colonoscopy
  • 3.3.5: Virtual Colonoscopy
• 3.4: Global Colorectal Cancer Market by Treatment
  • 3.4.1: Surgery and Radiation Therapy
  • 3.4.2: Chemotherapy
  • 3.4.3: Targeted Therapies
  • 3.4.4: Resistance to Pharmacological Therapies
  • 3.4.5: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Colorectal Cancer Market by Region
• 4.2: North American Colorectal Cancer Market
  • 4.2.2: North American Colorectal Cancer Market by Treatment: Surgery and Radiation Therapy, Chemotherapy, Targeted Therapies, Resistance to Pharmacological Therapies, and Others
• 4.3: European Colorectal Cancer Market
  • 4.3.1: European Colorectal Cancer Market by Diagnosis: Digital Rectal Examination, Fecal Occult Blood Test, Flexible Sigmoidoscopy, Colonoscopy, and Virtual Colonoscopy
  • 4.3.2: European Colorectal Cancer Market by Treatment: Surgery and Radiation Therapy, Chemotherapy, Targeted Therapies, Resistance to Pharmacological Therapies, and Others
• 4.4: APAC Colorectal Cancer Market
  • 4.4.1: APAC Colorectal Cancer Market by Diagnosis: Digital Rectal Examination, Fecal Occult Blood Test, Flexible Sigmoidoscopy, Colonoscopy, and Virtual Colonoscopy
  • 4.4.2: APAC Colorectal Cancer Market by Treatment: Surgery and Radiation Therapy, Chemotherapy, Targeted Therapies, Resistance to Pharmacological Therapies, and Others
• 4.5: ROW Colorectal Cancer Market
  • 4.5.1: ROW Colorectal Cancer Market by Diagnosis: Digital Rectal Examination, Fecal Occult Blood Test, Flexible Sigmoidoscopy, Colonoscopy, and Virtual Colonoscopy
  • 4.5.2: ROW Colorectal Cancer Market by Treatment: Surgery and Radiation Therapy, Chemotherapy, Targeted Therapies, Resistance to Pharmacological Therapies, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Colorectal Cancer Market by Diagnosis
  • 6.1.2: Growth Opportunities for the Global Colorectal Cancer Market by Treatment
  • 6.1.3: Growth Opportunities for the Global Colorectal Cancer Market by Region
• 6.2: Emerging Trends in the Global Colorectal Cancer Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Colorectal Cancer Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Colorectal Cancer Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Abbott Diagnostics
• 7.2: Alere
• 7.3: Beckman Coulter
• 7.4: Clinical Genomics
• 7.5: Companion Dx
• 7.6: Hoffmann La Roche
• 7.7: Debiopharm
• 7.8: Vaccinogen BD